BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

988 related articles for article (PubMed ID: 33282565)

  • 21. Common gene signatures and key pathways in hypopharyngeal and esophageal squamous cell carcinoma: Evidence from bioinformatic analysis.
    Zhou R; Liu D; Zhu J; Zhang T
    Medicine (Baltimore); 2020 Oct; 99(42):e22434. PubMed ID: 33080677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening and identification of hub genes in pancreatic cancer by integrated bioinformatics analysis.
    Chen Q; Yu D; Zhao Y; Qiu J; Xie Y; Tao M
    J Cell Biochem; 2019 Dec; 120(12):19496-19508. PubMed ID: 31297881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
    Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
    Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive analysis of abnormal expression, prognostic value and oncogenic role of the hub gene FN1 in pancreatic ductal adenocarcinoma
    Lei X; Chen G; Li J; Wen W; Gong J; Fu J
    PeerJ; 2021; 9():e12141. PubMed ID: 34567847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Hub Genes in Pancreatic Ductal Adenocarcinoma Using Bioinformatics Analysis.
    Wang C; Guo J; Zhao X; Jia J; Xu W; Wan P; Sun C
    Iran J Public Health; 2021 Nov; 50(11):2238-2245. PubMed ID: 35223598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of dynamic molecular networks for pancreatic ductal adenocarcinoma progression.
    Pan Z; Li L; Fang Q; Zhang Y; Hu X; Qian Y; Huang P
    Cancer Cell Int; 2018; 18():214. PubMed ID: 30598639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods.
    Li Z; Lin Y; Cheng B; Zhang Q; Cai Y
    Front Genet; 2021; 12():571231. PubMed ID: 33767726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of key regulators of pancreatic ductal adenocarcinoma using bioinformatics analysis of microarray data.
    Li N; Zhao X; You S
    Medicine (Baltimore); 2019 Jan; 98(2):e14074. PubMed ID: 30633213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of key candidate genes and biological pathways in bladder cancer.
    Gao X; Chen Y; Chen M; Wang S; Wen X; Zhang S
    PeerJ; 2018; 6():e6036. PubMed ID: 30533316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
    Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
    BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
    Zhou J; Hui X; Mao Y; Fan L
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of CXCL10 as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.
    Qu G; Wang H; Yan H; Liu G; Wu M
    Front Oncol; 2022; 12():857619. PubMed ID: 35296026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioinformatic Analysis Combined With Experimental Validation Reveals Novel Hub Genes and Pathways Associated With Focal Segmental Glomerulosclerosis.
    Hou YP; Diao TT; Xu ZH; Mao XY; Wang C; Li B
    Front Mol Biosci; 2021; 8():691966. PubMed ID: 35059432
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of genes and pathways in esophageal adenocarcinoma using bioinformatics analysis.
    He F; Ai B; Tian L
    Biomed Rep; 2018 Oct; 9(4):305-312. PubMed ID: 30233782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Metastasis-Associated Biomarkers in Synovial Sarcoma Using Bioinformatics Analysis.
    Song Y; Liu X; Wang F; Wang X; Cheng G; Peng C
    Front Genet; 2020; 11():530892. PubMed ID: 33061942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Key Genes Involved in Diabetic Peripheral Neuropathy Progression and Associated with Pancreatic Cancer.
    Jian L; Yang G
    Diabetes Metab Syndr Obes; 2020; 13():463-476. PubMed ID: 32110079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of survival-associated biomarkers based on three datasets by bioinformatics analysis in gastric cancer.
    Yin LK; Yuan HY; Liu JJ; Xu XL; Wang W; Bai XY; Wang P
    World J Clin Cases; 2023 Jul; 11(20):4763-4787. PubMed ID: 37584004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioinformatic Analysis Suggests That Three Hub Genes May Be a Vital Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma.
    Chang X; Yang MF; Fan W; Wang LS; Yao J; Li ZS; Li DF
    J Comput Biol; 2020 Nov; 27(11):1595-1609. PubMed ID: 32216644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Analysis of Potential Diagnostic and Therapeutic Targets for the Occurrence and Development of Gastric Cancer Based on Bioinformatics.
    Ding C; Zhang Q; Jiang X; Wei D; Xu S; Li Q; Wu M; Wang H
    Comput Math Methods Med; 2022; 2022():4321466. PubMed ID: 35756405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.